Join Our Newsletter

RegeneRx Biopharmaceuticals, Inc. - RGRX

RSI %R Tweets Wolf Odds
24 -83 0 31.905%

Industry: Biotechnology / Sector: Healthcare

RGRX Chart

RGRX Quote

Prev Close: 0.185
Open: 0.1850
Last Trade: 0.18
Change %: -2.700%
Change: -0.0050000
Volume: 42823
Avg Vol: 103953
Relative Vol: 0.41
Day Range: 0.17005 -0.185
52-Week Range: 0.22 - 0.40
Market Cap: 29.93M
Float: 51.4M
Shares Outstanding: 106.88M
Insider Owned: 52.30%
Institution Owned: 0.14%
Beta: 1.77
PE Ratio: 0.00
EPS: -0.01

RGRX Detailed Stats

RSI:24.44 %K:16.67 Wolf Odds: 31.905% Tweets Today:0 SMA14:0.2156
stochRSI:0.37 %D:25.37 Wolf Trend:0.27 Tweet Avg:2 Pivot Price:0.1783500
%R:-83.33 %B:-0.05 Wolf 3-Day:0.22 Avg. Change 3-Day:-3.323% Resistance 1:0.1866500
MFI:33.53 Bandwidth:0.299175 Wolf 7-Day:0.17 Avg. Change 7-Day:-2.723% Resistance 2:0.1933000
WolfPeak:0.28 Vortex Indicator:-0.24 Wolf 14-Day:0.19 Avg. Change 14-Day:-1.40% Support 1:0.1717000
ROC 7/14:-18.1818/-21.7391 Aroon Oscillator:-92.8571 EOM:0.148836 Relative Vol:0.41 Support 2:0.1634000
RSI Alert:None WolfPeak Alert:None Vortex Alert:None Aroon Alert:None EOM Alert:None

Featured News *

RGRX News

RGRX Description

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It also evaluates the commercial development of peptide fragments and derivatives of T4 for potential cosmeceutical and other personal care uses. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was founded in 1982 and is headquartered in Rockville, Maryland.
Website: http://www.regenerx.com

RGRX Comments

Recent RGRX Tweets

Powered by Ekonomys ver. 9

StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell